Close

BTIG Affirms Ophthotech (OPHT) at 'Buy'; Sees Publication of Fovista Phase 2b Data Easing Investor Worries

Go back to BTIG Affirms Ophthotech (OPHT) at 'Buy'; Sees Publication of Fovista Phase 2b Data Easing Investor Worries
OPHTHOTECH (NASDAQ: OPHT) Delayed: 1.39 --0 (-0%)
Previous Close $1.39    52 Week High $80.00 
Open $29.35    52 Week Low $29.85 
Day High $1.39    P/E N/A 
Day Low $1.39    EPS $-0.96 
Volume 1,732,412